Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Bosutinib in Adult Patients With Recurrent Glioblastoma
An Open Label, Phase 2 Trial of Orally Administered Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma (GBM)
Status: Enrolling
Updated:  10/18/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
Bosutinib in Adult Patients With Recurrent Glioblastoma
An Open Label, Phase 2 Trial of Orally Administered Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma (GBM)
Status: Enrolling
Updated: 10/18/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Bosutinib in Adult Patients With Recurrent Glioblastoma
An Open Label, Phase 2 Trial of Orally Administered Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma (GBM)
Status: Enrolling
Updated:  10/18/2013
Massachusetts General Hospital
mi
from
Boston, MA
Bosutinib in Adult Patients With Recurrent Glioblastoma
An Open Label, Phase 2 Trial of Orally Administered Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma (GBM)
Status: Enrolling
Updated: 10/18/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Low-Dose Naltrexone for Glioma Patients
Effects of Low-Dose Naltrexone on Quality of Life in High-Grade Glioma Patients: A Placebo-Controlled, Double-Blind Randomized Trial
Status: Enrolling
Updated:  11/4/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Low-Dose Naltrexone for Glioma Patients
Effects of Low-Dose Naltrexone on Quality of Life in High-Grade Glioma Patients: A Placebo-Controlled, Double-Blind Randomized Trial
Status: Enrolling
Updated: 11/4/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated:  11/5/2013
UCSD San Diego
mi
from
La Jolla, CA
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated: 11/5/2013
UCSD San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated:  11/5/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated: 11/5/2013
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated:  11/5/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated: 11/5/2013
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated:  11/5/2013
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status: Enrolling
Updated: 11/5/2013
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Status: Enrolling
Updated:  12/16/2013
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Status: Enrolling
Updated: 12/16/2013
UNC Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Tegaderm and Visual Evoked Potentials
A Pilot Study: Does Tegaderm Placement on Eyes to Prevent Lagophthalmos Affect Visual Evoked Potentials Data Latency and Amplitude
Status: Enrolling
Updated:  4/2/2014
University Hospital
mi
from
Newark, NJ
Tegaderm and Visual Evoked Potentials
A Pilot Study: Does Tegaderm Placement on Eyes to Prevent Lagophthalmos Affect Visual Evoked Potentials Data Latency and Amplitude
Status: Enrolling
Updated: 4/2/2014
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme
Early Assessment of Tumor Response to Therapy Using Ferumoxytol (Code 7228) as an MR Contrast Agent in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated:  5/9/2014
Oregon Health and Science University
mi
from
Portland, OR
Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme
Early Assessment of Tumor Response to Therapy Using Ferumoxytol (Code 7228) as an MR Contrast Agent in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 5/9/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma: Assessment of Tolerability and In Vivo Expansion γδ T-Cells
Status: Enrolling
Updated:  5/9/2014
University of Alabama at Birmingham/Children's of Alabama
mi
from
Birmingham, AL
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma: Assessment of Tolerability and In Vivo Expansion γδ T-Cells
Status: Enrolling
Updated: 5/9/2014
University of Alabama at Birmingham/Children's of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
Pilot Study to Compare Dynamic MR Imaging Changes in Patients With Recurrent High Grade Glioma, Receiving an Antiangiogenic Drug, Bevacizumab, Versus Dexamethasone. Dual Agent MR Imaging Study, Using Gadolinium and Ferumoxytol (Code 7228)
Status: Enrolling
Updated:  5/12/2014
Oregon Health and Science University
mi
from
Portland, OR
Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
Pilot Study to Compare Dynamic MR Imaging Changes in Patients With Recurrent High Grade Glioma, Receiving an Antiangiogenic Drug, Bevacizumab, Versus Dexamethasone. Dual Agent MR Imaging Study, Using Gadolinium and Ferumoxytol (Code 7228)
Status: Enrolling
Updated: 5/12/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization
Status: Enrolling
Updated:  5/21/2014
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization
Status: Enrolling
Updated: 5/21/2014
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients
A Pilot Study to Determine the Effectiveness of Bioelectrical Impedance Analysis as a Clinical Assessment Tool of Nutrition Status in Glioblastoma Multiforme Patients (The BEAM Study [BIA Effectiveness as Assessment Tool for Glioblastoma Multiforme (GBM) Patients])
Status: Enrolling
Updated:  7/31/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients
A Pilot Study to Determine the Effectiveness of Bioelectrical Impedance Analysis as a Clinical Assessment Tool of Nutrition Status in Glioblastoma Multiforme Patients (The BEAM Study [BIA Effectiveness as Assessment Tool for Glioblastoma Multiforme (GBM) Patients])
Status: Enrolling
Updated: 7/31/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated:  8/12/2014
Childrens National Medical Center
mi
from
Washington,
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/12/2014
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated:  8/12/2014
National Cancer Institute
mi
from
Bethesda, MD
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/12/2014
National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated:  8/12/2014
Childrens Hospital Boston, Dana-Farber Cancer Institute.
mi
from
Boston, MA
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/12/2014
Childrens Hospital Boston, Dana-Farber Cancer Institute.
mi
from
Boston, MA
Click here to add this to my saved trials
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated:  8/12/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Phase 1 Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/12/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated:  11/4/2014
NJ Neuroscience Institute, JFK Medical Center
mi
from
Edison, NJ
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated: 11/4/2014
NJ Neuroscience Institute, JFK Medical Center
mi
from
Edison, NJ
Click here to add this to my saved trials
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated:  11/4/2014
Winthrop University Hospital
mi
from
Mineola, NY
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated: 11/4/2014
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated:  11/4/2014
Univ of Rochester Medical Center
mi
from
Rochester, NY
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated: 11/4/2014
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated:  11/4/2014
Hospital Británico
mi
from
Ciudad Autónoma de Buenos Aires,
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Efficacy and Safety of AP 12009 in Adult Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma as Compared to Standard Chemotherapy Treatment: A Randomized, Actively Controlled, Open Label Clinical Phase III Study.
Status: Enrolling
Updated: 11/4/2014
Hospital Británico
mi
from
Ciudad Autónoma de Buenos Aires,
Click here to add this to my saved trials
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Phase I / II Adaptive Randomized Trial of Vorinostat, Erlotinib and Temozolomide in Adults With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  11/7/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Phase I / II Adaptive Randomized Trial of Vorinostat, Erlotinib and Temozolomide in Adults With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 11/7/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Effect of Non-Pharmacologic Interventions on Risk Factors of Cardiovascular Disease in Survivors of Childhood Leukemia, Lymphoma and Brain Tumor
Status: Enrolling
Updated:  12/2/2014
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Effect of Non-Pharmacologic Interventions on Risk Factors of Cardiovascular Disease in Survivors of Childhood Leukemia, Lymphoma and Brain Tumor
Status: Enrolling
Updated: 12/2/2014
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Phase I/II Clinical Trial of the Safety, Tolerability, and Anti-tumor Efficacy of the IGF-1R Inhibitor, AXL1717 (Picropodophyllin), in the Treatment of Recurrent Malignant Astrocytomas
Status: Enrolling
Updated:  1/8/2015
Rush University Medical Center
mi
from
Chicago, IL
Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Phase I/II Clinical Trial of the Safety, Tolerability, and Anti-tumor Efficacy of the IGF-1R Inhibitor, AXL1717 (Picropodophyllin), in the Treatment of Recurrent Malignant Astrocytomas
Status: Enrolling
Updated: 1/8/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Derivation of Tumor Specific Hybridomas
Vaccination of Patients With Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas
Status: Enrolling
Updated:  1/26/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Derivation of Tumor Specific Hybridomas
Vaccination of Patients With Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas
Status: Enrolling
Updated: 1/26/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Derivation of Tumor Specific Hybridomas
Vaccination of Patients With Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas
Status: Enrolling
Updated:  1/26/2015
University of Vermont/Vermont Cancer Center
mi
from
Burlington, VT
Derivation of Tumor Specific Hybridomas
Vaccination of Patients With Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas
Status: Enrolling
Updated: 1/26/2015
University of Vermont/Vermont Cancer Center
mi
from
Burlington, VT
Click here to add this to my saved trials
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
Status: Enrolling
Updated:  4/6/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
Status: Enrolling
Updated: 4/6/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase IIa Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Status: Enrolling
Updated:  7/2/2015
Stanford University Cancer Institute
mi
from
Stanford, CA
Phase IIa Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Status: Enrolling
Updated: 7/2/2015
Stanford University Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated:  7/7/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated: 7/7/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated:  7/7/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated: 7/7/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated:  7/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas: Multi-Institutional Trial
Status: Enrolling
Updated: 7/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Irinotecan in Treating Patients With Recurrent Glioma
A Phase II Trial of Irinotecan in Recurrent Glioma
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials